Report #2885297

Received Feb 12, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: TN
Recovered: Recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	—

Symptoms (1)

Influenza like illness

Symptom narrative

flu-like symptoms; This non-serious case was reported by a physician and described the occurrence of influenza-like symptoms in a 55-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced influenza-like symptoms (Verbatim: flu-like symptoms). The outcome of the influenza-like symptoms was resolved (duration 6 hrs). It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix. It was unknown if the company considered the influenza-like symptoms to be related to Shingrix. Additional Information: GSK Receipt Date: 04-FEB-2026 The symptoms lasted about 6 hours the day of the vaccine and resolved the following day. The batch number was not provided, and we are unable to contact the reporter.